Welcome to the registration site for the satellite symposium
Clinical applications of evidence-based medicine for effectively managing Type 2 diabetes: considerations for incretin therapies
to be held during the
36th Annual Scientific Meeting of the Research Society for the Study of Diabetes in India (RSSDI)
Sunday, 23 November 2008
(13:30h – 15:00h)
Hyderabad International Convention Centre
Hyderabad, India
Educational Objectives
Scientific Agenda and Faculty
WorldWIDE has received funding from the following sponsors:
AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline,
Merck Sharp & Dohme,
Novartis, Pfizer Inc, and sanofi-aventis
